Drug-induced liver injury secondary to tamoxifen.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
05 Jun 2024
Historique:
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 5 6 2024
Statut: epublish

Résumé

Tamoxifen is a non-steroidal selective oestrogen receptor modulator commonly used in the treatment of breast cancer. It is associated with the development of fatty liver and steatohepatitis however drug-induced liver injury is rare. We report a woman in her 50s who developed malaise with an acute moderate aminotransferase elevation without jaundice 6 months after starting tamoxifen. She was not commenced on any other recent drugs and extensive investigation including infective and autoimmune liver screen, cross-sectional imaging and FibroScan were unremarkable. Liver biopsy revealed moderate lobular hepatitis with hepatocyte drop-out. Tamoxifen was ceased and the liver enzymes showed resolution over the following 3 months and improvement of her symptoms.

Identifiants

pubmed: 38839414
pii: 17/6/e260098
doi: 10.1136/bcr-2024-260098
pii:
doi:

Substances chimiques

Tamoxifen 094ZI81Y45
Antineoplastic Agents, Hormonal 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Deloshaan Subhaharan (D)

Department of Hepatology, Sunshine Coast University Hospital, Birtinya, Queensland, Australia natalie.commins@gmail.com deloshaan.subhaharan@health.qld.gov.au.

Grace Murphy (G)

Department of Medical Oncology, Sunshine Coast University Hospital, Birtinya, Queensland, Australia.

Natalie Commins (N)

Department of Hepatology, Sunshine Coast University Hospital, Birtinya, Queensland, Australia natalie.commins@gmail.com deloshaan.subhaharan@health.qld.gov.au.

Mary Azer (M)

Department of Medical Oncology, Sunshine Coast University Hospital, Birtinya, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH